相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe
Mateusz Sokolski et al.
AMERICAN JOURNAL OF MEDICINE (2021)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
The Consequences of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials
Emilia Bagiella et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Stefan D. Anker et al.
EUROPEAN HEART JOURNAL (2020)
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
Marion M. Mafham et al.
LANCET (2020)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Stefan D. Anker et al.
EUROPEAN HEART JOURNAL (2020)
Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis
Stefan D. Anker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials
Brian Claggett et al.
CIRCULATION (2018)
Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function
Martijn F. Hoes et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis
Vojtech Melenovsky et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Iron deficiency and risk of early readmission following a hospitalization for acute heart failure
Julio Nunez et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2015)
Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure
Ewa A. Jankowska et al.
EUROPEAN HEART JOURNAL (2014)
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
Jennifer K. Rogers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Iron deficiency and health-related quality of life in chronic heart failure: Results from a multicenter European study
Cristina Enjuanes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Sample size calculation for comparing two negative binomial rates
Haiyuan Zhu et al.
STATISTICS IN MEDICINE (2014)
Iron deficiency in chronic heart failure: An international pooled analysis
IJsbrand T. Klip et al.
AMERICAN HEART JOURNAL (2013)
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
Ewa A. Jankowska et al.
EUROPEAN HEART JOURNAL (2013)
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure The ASTRONAUT Randomized Trial
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure
Ewa A. Jankowska et al.
JOURNAL OF CARDIAC FAILURE (2011)
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program
Christopher M. O'Connor et al.
AMERICAN HEART JOURNAL (2010)
Iron deficiency: an ominous sign in patients with systolic chronic heart failure
Ewa A. Jankowska et al.
EUROPEAN HEART JOURNAL (2010)
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial
Marvin A. Konstam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
分享论文
